Vaccines Studies open to developing countries

According to an article at Fierce Vaccines, the University of Sienna and Novartis Vaccines and Diagnostics will be partnering to educate and develop vaccines for the developing world. Groups of doctors, largely from African and Asian countries, will team together to figure out what is best when it come to developing vaccines in their country such as:

Key factors like engineering a vaccine's resistance to high temperatures and use of local storage facilities would be built into the research programs, pushing the researchers to come up with treatments that are ideal for that environment. And these new experts on vaccine development will be free to work with any developers.

Professor Ranuccio Nuti, coordinator of the Technical-Scientific Committee states:
"Clinical research and development of vaccines, along with immunology, infectivology and biostatistics, are some of the core subjects that will be addressed during the program. Our aim is to provide these medical professionals with the knowledge necessary to meet the demands arising in the area of neglected diseases as well as to prepare them to react proactively to situations such as the recent outbreak of the H1N1 virus in Mexico."

To connect with more professionals in the Vaccines field, join our Vaccines Development Forum Group on LinkedIn or join us in Boston September 23-25 for the Vaccines Development Forum.

Share this article with your social network, just click below to share now!

Share |